Quigley Seeks Approval Of Trust For Asbestos Claims
Under the Chapter 11 plan, Quigley and Pfizer will shell out $645 million for existing and future asbestos-related claims.
The reorganization plan has already won the conditional support of the court-appointed representative for future asbestos claimants. But the plan has drawn fire from insurance companies, which...
To view the full article, register now.